Serial triggering of many T-cell receptors by a few peptide???MHC complexes, Nature, vol.375, issue.6527, pp.148-151, 1995. ,
DOI : 10.1038/375148a0
Phenotypic Analysis of Antigen-Specific T Lymphocytes, Science, vol.274, issue.5284, pp.94-96, 1996. ,
DOI : 10.1126/science.274.5284.94
Production of soluble MHC class II proteins with covalently bound single peptides, Nature, vol.369, issue.6476, pp.151-154, 1994. ,
DOI : 10.1038/369151a0
Detection of Antigen-Specific T Cells with Multivalent Soluble Class II MHC Covalent Peptide Complexes, Immunity, vol.8, issue.6, pp.675-682, 1998. ,
DOI : 10.1016/S1074-7613(00)80572-5
Use of soluble peptide-DR4 tetramers to detect synovial T cells specific for cartilage antigens in patients with rheumatoid arthritis, Proceedings of the National Academy of Sciences, vol.97, issue.1, pp.291-296, 2000. ,
DOI : 10.1073/pnas.97.1.291
The Relationship of MHC-Peptide Binding and T Cell Activation Probed Using Chemically Defined MHC Class II Oligomers, Immunity, vol.12, issue.3, pp.241-250, 2000. ,
DOI : 10.1016/S1074-7613(00)80177-6
Cutting Edge: Detection of Antigen-Specific CD4+ T Cells by HLA-DR1 Oligomers Is Dependent on the T Cell Activation State, The Journal of Immunology, vol.166, issue.2, pp.741-745, 2001. ,
DOI : 10.4049/jimmunol.166.2.741
Staining of Celiac Disease-Relevant T Cells by Peptide-DQ2 Multimers, The Journal of Immunology, vol.167, issue.9, pp.4861-4868, 2001. ,
DOI : 10.4049/jimmunol.167.9.4861
MHC class II tetramers identify peptide-specific human CD4+ T cells proliferating in response to influenza A antigen, Journal of Clinical Investigation, vol.104, issue.12, pp.63-67, 1999. ,
DOI : 10.1172/JCI8476
Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices, Nat. Biotechnol, vol.17, pp.555-561, 1999. ,
Tetramer-Guided Epitope Mapping: Rapid Identification and Characterization of Immunodominant CD4+ T Cell Epitopes from Complex Antigens, The Journal of Immunology, vol.166, issue.11, pp.6665-6670, 2001. ,
DOI : 10.4049/jimmunol.166.11.6665
Rapid epitope identification from complex class-II-restricted T-cell antigens, Trends in Immunology, vol.22, issue.11, pp.583-588, 2001. ,
DOI : 10.1016/S1471-4906(01)02038-5
Functional Heterogeneity of Vaccine-Induced CD8+ T Cells, The Journal of Immunology, vol.168, issue.11, pp.5933-5942, 2002. ,
DOI : 10.4049/jimmunol.168.11.5933
Activated human epitope-specific T cells identified by class II tetramers reside within a CD4high, proliferating subset, International Immunology, vol.13, issue.6, pp.799-806, 2001. ,
DOI : 10.1093/intimm/13.6.799
HLA-DQ Tetramers Identify Epitope-Specific T Cells in Peripheral Blood of Herpes Simplex Virus Type 2-Infected Individuals: Direct Detection of Immunodominant Antigen-Responsive Cells, The Journal of Immunology, vol.164, issue.8, pp.4244-4249, 2000. ,
DOI : 10.4049/jimmunol.164.8.4244
Distinct T Cell Interactions with HLA Class II Tetramers Characterize a Spectrum of TCR Affinities in the Human Antigen-Specific T Cell Response, The Journal of Immunology, vol.165, issue.12, pp.6994-6998, 2000. ,
DOI : 10.4049/jimmunol.165.12.6994
Detection of GAD65-Specific T-Cells by Major Histocompatibility Complex Class II Tetramers in Type 1 Diabetic Patients and At-Risk Subjects, Diabetes, vol.51, issue.5, pp.1375-1382, 2002. ,
DOI : 10.2337/diabetes.51.5.1375
Direct enumeration of Borrelia-reactive CD4 T cells ex vivo by using MHC class II tetramers, Proceedings of the National Academy of Sciences, vol.97, issue.21, pp.11433-11438, 2000. ,
DOI : 10.1073/pnas.190335897
Initiation of Signal Transduction through the T Cell Receptor Requires the Multivalent Engagement of Peptide/MHC Ligands, Immunity, vol.9, issue.4, pp.459-466, 1998. ,
DOI : 10.1016/S1074-7613(00)80629-9
Direct observation of ligand recognition by T cells, Nature, vol.90, issue.6909, pp.845-849, 2002. ,
DOI : 10.1126/science.282.5397.2266
Ligandspecific oligomerization of T-cell receptor molecules, Nature, vol.387, pp.617-620, 1997. ,
Serial triggering of TCRs: a basis for the sensitivity and specificity of antigen recognition, Immunology Today, vol.18, issue.6, pp.299-304, 1997. ,
DOI : 10.1016/S0167-5699(97)80027-8
Potent T Cell Activation with Dimeric Peptide???Major Histocompatibility Complex Class II Ligand: The Role of CD4 Coreceptor, The Journal of Experimental Medicine, vol.136, issue.9, pp.1633-1640, 1998. ,
DOI : 10.1002/eji.1830240427
Antigen-Specific Signaling by a Soluble, Dimeric Peptide/Major Histocompatibility Complex Class II/Fc Chimera Leading to T Helper Cell Type 2 Differentiation, The Journal of Experimental Medicine, vol.15, issue.4, pp.543-553, 1999. ,
DOI : 10.1146/annurev.immunol.15.1.563
Kinetics of T-cell receptor binding by bivalent HLA-DR.Peptide complexes that activate antigen-specific human T-cells ,
Two-step binding mechanism for T-cell receptor recognition of peptide???MHC, Nature, vol.14, issue.6897, pp.552-556, 2002. ,
DOI : 10.1107/S0021889891004399
Self-recognition promotes the foreign antigen sensitivity of naive T lymphocytes, Nature, vol.151, issue.6914, pp.429-434, 2002. ,
DOI : 10.1084/jem.186.5.757
Costimulation and endogenous MHC ligands contribute to T cell recognition, Nature Immunology, vol.3, issue.1, pp.42-47, 2002. ,
DOI : 10.1038/ni741
Functional Responses and Costimulator Dependence of Memory CD4+ T Cells, The Journal of Immunology, vol.164, issue.1, pp.265-272, 2000. ,
DOI : 10.4049/jimmunol.164.1.265
Purified MHC class I and peptide complexes activate naive CD8+ T cells independently of the CD28/B7 and LFA-1/ICAM-1 costimulatory interactions, J. Immunol, 1998. ,
New perspectives of C1328-137-mediated T cell costimulation, Immunity, vol.2, issue.6, pp.555-559, 1995. ,
DOI : 10.1016/1074-7613(95)90000-4
Anergy Induction by Dimeric TCR Ligands, The Journal of Immunology, vol.166, issue.8, pp.5279-5285, 2001. ,
DOI : 10.4049/jimmunol.166.8.5279
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3414419
Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells, Nat. Biotechnol, vol.18, pp.405-409, 2000. ,
Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB, Nature Biotechnology, vol.20, issue.2, pp.28-32, 2002. ,
DOI : 10.1038/nbt0202-143
HLA tetramer-based artificial antigen-presenting cells for stimulation of CD4+ T cells, Clinical Immunology, vol.106, issue.1, pp.16-22, 2003. ,
DOI : 10.1016/S1521-6616(02)00017-7
Detection of Low-Avidity CD4+ T Cells Using Recombinant Artificial APC: Following the Antiovalbumin Immune Response, The Journal of Immunology, vol.170, issue.1, pp.123-131, 2003. ,
DOI : 10.4049/jimmunol.170.1.123
Tumor-Specific CD4+ T Lymphocytes from Cancer Patients Are Required for Optimal Induction of Cytotoxic T Cells Against the Autologous Tumor, The Journal of Immunology, vol.164, issue.7, pp.3902-3912, 2000. ,
DOI : 10.4049/jimmunol.164.7.3902
Tumor-Specific CD4+ T Cells Have a Major "Post-Licensing" Role in CTL Mediated Anti-Tumor Immunity, The Journal of Immunology, vol.165, issue.11, pp.6047-6055, 2000. ,
DOI : 10.4049/jimmunol.165.11.6047
T Cells in the Antitumor Immune Response, The Journal of Experimental Medicine, vol.156, issue.12, pp.2357-2368, 1998. ,
DOI : 10.1084/jem.179.2.447
The role of CD4+ T cell responses in antitumor immunity, Current Opinion in Immunology, vol.10, issue.5, pp.588-594, 1998. ,
DOI : 10.1016/S0952-7915(98)80228-8
The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity, Trends in Immunology, vol.22, issue.5, pp.269-276, 2001. ,
DOI : 10.1016/S1471-4906(01)01896-8
Down-regulation of diabetogenic CD4+ T cells by a soluble dimeric peptide???MHC class II chimera, Nature Immunology, vol.3, issue.4, pp.383-391, 2002. ,
DOI : 10.1038/ni770
A Single-Chain Class II MHC-IgG3 Fusion Protein Inhibits Autoimmune Arthritis by Induction of Antigen-Specific Hyporesponsiveness, The Journal of Immunology, vol.168, issue.5, pp.2554-2559, 2002. ,
DOI : 10.4049/jimmunol.168.5.2554
Antigen-Specific Blockade of T Cells In Vivo Using Dimeric MHC Peptide, The Journal of Immunology, vol.167, issue.5, pp.2555-2560, 2001. ,
DOI : 10.4049/jimmunol.167.5.2555
T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis, Science, vol.263, issue.5150, pp.1139-1143, 1994. ,
DOI : 10.1126/science.7509084
Activation-induced cell death, Current Opinion in Immunology, vol.13, issue.3, pp.356-362, 2001. ,
DOI : 10.1016/S0952-7915(00)00227-2
Autocrine T-cell suicide mediated by APO-1/(Fas/CD95), Nature, vol.373, issue.6513, pp.438-441, 1995. ,
DOI : 10.1038/373438a0
Fas- ligand interaction mediates activation-induced apoptosis in T-cell hybridomas, Cell-autonomous Fas Nature, vol.373, issue.CD95, pp.441-444, 1995. ,
Functions of CD40 and Its Ligand, gp39 (CD40L), Critical Reviews??? in Immunology, vol.16, issue.1, pp.59-108, 1996. ,
DOI : 10.1615/CritRevImmunol.v16.i1.40
Tumor necrosis factor (TNF-??) and lymphotoxin (TNF-??), Current Opinion in Immunology, vol.4, issue.3, pp.327-332, 1992. ,
DOI : 10.1016/0952-7915(92)90084-R
Differential regulation of lymphotoxin and tumor necrosis factor genes in human T lymphocytes, J. Biol. Chem, vol.266, pp.7108-7113, 1991. ,
T cell life and death signalling via TNF-receptor family members, Current Opinion in Immunology, vol.12, issue.3, pp.316-322, 2000. ,
DOI : 10.1016/S0952-7915(00)00093-5
Signaling by the TNF Receptor Superfamily and T Cell Homeostasis, Immunity, vol.13, issue.4, pp.419-422, 2000. ,
DOI : 10.1016/S1074-7613(00)00041-8
Role of 4-1BB in immune responses, Seminars in Immunology, vol.10, issue.6, pp.481-489, 1998. ,
DOI : 10.1006/smim.1998.0157
Identification and characterization of murine caspase-14, a new member of the caspase family, Cancer Res, vol.58, pp.5201-5205, 1998. ,
bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death, Cell, vol.74, issue.4, pp.597-608, 1993. ,
DOI : 10.1016/0092-8674(93)90508-N
Life-or-death decisions by the Bcl-2 protein family, Trends in Biochemical Sciences, vol.26, issue.1, pp.61-66, 2001. ,
DOI : 10.1016/S0968-0004(00)01740-0
Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory, Nature Medicine, vol.7, issue.8, pp.913-919, 2001. ,
DOI : 10.1038/90950
Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood, Journal of Clinical Investigation, vol.111, issue.2, pp.217-223, 2003. ,
DOI : 10.1172/JCI200316409
Prevention of Autoimmune Diabetes With Nonactivating Anti-CD3 Monoclonal Antibody, Diabetes, vol.41, issue.3, pp.385-391, 1992. ,
DOI : 10.2337/diab.41.3.385
Anti-CD3 Monoclonal Antibody in New-Onset Type 1 Diabetes Mellitus, New England Journal of Medicine, vol.346, issue.22, pp.1692-1698, 2002. ,
DOI : 10.1056/NEJMoa012864
Immunotherapy of insulin-dependent diabetes mellitus, Current Opinion in Immunology, vol.14, issue.5, pp.652-659, 2002. ,
DOI : 10.1016/S0952-7915(02)00375-8
CD3-specific antibody-induced active tolerance: from bench to bedside, Nature Reviews Immunology, vol.3, issue.2, pp.123-132, 2003. ,
DOI : 10.1038/nri1000
Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments, Journal of Neuroimmunology, vol.16, issue.1, pp.440-445, 1988. ,
DOI : 10.1016/0165-5728(87)90246-3
A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis., Proceedings of the National Academy of Sciences, vol.88, issue.21, pp.9633-9637, 1991. ,
DOI : 10.1073/pnas.88.21.9633
Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23)., Proceedings of the National Academy of Sciences, vol.93, issue.2, pp.956-960, 1996. ,
DOI : 10.1073/pnas.93.2.956
Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes???prone mice, Nature Medicine, vol.150, issue.12, pp.1348-1353, 1996. ,
DOI : 10.1016/0167-4781(93)90056-J
Peptide therapy for diabetes in NOD mice, The Lancet, vol.343, issue.8899, pp.704-706, 1994. ,
DOI : 10.1016/S0140-6736(94)91582-2
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand, Nat. Med, vol.6, pp.1167-1175, 2000. ,
Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. The Altered Peptide Ligand in Relapsing MS Study Group, Nat. Med, vol.6, pp.1176-1182, 2000. ,
Oral insulin administration and residual (??-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial, The Lancet, vol.356, issue.9229, pp.545-549, 2000. ,
DOI : 10.1016/S0140-6736(00)02579-4
??-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial, The Lancet, vol.358, issue.9295, pp.1749-1753, 2001. ,
DOI : 10.1016/S0140-6736(01)06801-5
Failure to demonstrate long-lived MHC saturation both in vitro and in vivo. Implications for therapeutic potential of MHC-blocking peptides, J. Immunol, vol.152, pp.4310-4319, 1994. ,
Specific immunotherapy: one size does not fit all, Nature Medicine, vol.6, issue.10, pp.1098-1100, 2000. ,
DOI : 10.1038/80424
Enzymatically mediated engineering of multivalent MHC class II-peptide chimeras, Protein Engineering Design and Selection, vol.14, issue.3, 2001. ,
DOI : 10.1093/protein/14.3.195
EPITOPE SPREADING IN IMMUNE-MEDIATED DISEASES: IMPLICATIONS FOR IMMUNOTHERAPY, Nature Reviews Immunology, vol.4, issue.2, pp.85-95, 2002. ,
DOI : 10.1128/JVI.75.7.3077-3088.2001
Anti-CD38 autoantibodies: characterisation in new-onset type I diabetes and latent autoimmune diabetes of the adult (LADA) and comparison with other islet autoantibodies, Diabetologia, vol.45, pp.1667-1677, 2002. ,